FADS1 and acute myeloid leukemia: To assess the impact of FADS1 depletion on AML lipid composition, we extracted complex lipids from control and shFADS1-expressing NOMO1 and MOLM14 cells and performed global untargeted lipidomics (Fig. 4A).